Global Ophthalmic Viscosurgical Devices Market Outlook
Revenue, 2024
$1.1B
Forecast, 2034
$3.1B
CAGR, 2025 - 2034
11.4%
The Ophthalmic Viscosurgical Devices industry revenue is expected to be around $1.2 billion in 2025 and expected to showcase growth with 11.4% CAGR between 2025 and 2034. The steady rise in the Ophthalmic Viscosurgical Devices market is mainly due to the increasing occurrence of eye conditions like cataracts and glaucoma and the expanding elderly population worldwide driving this growth forward. The surge in demand for invasive eye surgeries and improvements in healthcare facilities in developing countries also play a significant role in the importance and continued relevance of these devices on a global scale. Moreover the growing emphasis on ensuring safety and comfort during ophthalmic procedures along with the uptick in disposable income levels is adding to the demand, for these specialized devices.
In today's eye surgeries the Ophthalmic Viscosurgical Devices play a crucial role by safeguarding and steadying the delicate structures of the eye throughout the surgical process. They serve purposes such as aiding in intraocular lens placement and preserving the anterior chambers depth during surgery. These devices usually consist of substances, with molecular weight that give them special viscoelastic characteristics.
Market Key Insights
- The Ophthalmic Viscosurgical Devices market is projected to grow from $1.1 billion in 2024 to $3.1 billion in 2034. This represents a CAGR of 11.4%, reflecting rising demand across Cataract Surgery, Corneal Transplantation and Glaucoma Surgery.
- Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Inc. are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Ophthalmic Viscosurgical Devices market and are expected to observe the growth CAGR of 8.3% to 12.0% between 2024 and 2030.
- Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 10.9% to 14.3%.
- Transition like Technological Advancements is expected to add $79 million to the Ophthalmic Viscosurgical Devices market growth by 2030.
- The Ophthalmic Viscosurgical Devices market is set to add $2.0 billion between 2024 and 2034, with manufacturer targeting Glaucoma Surgery & Corneal Transplantation Therapeutic Use projected to gain a larger market share.
- With
rising prevalence of ophthalmic disorders, and
technological advancements in ovds, Ophthalmic Viscosurgical Devices market to expand 194% between 2024 and 2034.
Opportunities in the Ophthalmic Viscosurgical Devices
The market for OVDs presents opportunities for companies to form strategic partnerships and collaborations that could also boost their market reach and diversify their product offerings by tapping into innovative technologies available through these alliances. Moreover engaging with manufacturers enables international firms to smoothly navigate regulatory challenges and establish a solid foundation, in previously untapped markets.
Growth Opportunities in North America and Asia-Pacific
North America, a leading region in the global market for Ophthalmic Viscosurgical Devices, is driven by advanced healthcare infrastructure and high prevalence of eye disorders. The regions market is further propelled by the presence of key players and their continuous research and development initiatives. The competitive landscape is characterized by strategic collaborations, mergers, and acquisitions aimed at expanding product portfolios and strengthening market positions. The growing aging population and the increasing demand for minimally invasive procedures present significant opportunities for the Ophthalmic Viscosurgical Devices market in North America.
The Asia-Pacific region is projected to witness substantial growth in the Ophthalmic Viscosurgical Devices market, fueled by increasing awareness about eye health and rising disposable income. Rapid urbanization and lifestyle changes have led to a surge in eye-related disorders, driving the demand for Ophthalmic Viscosurgical Devices. The regions market is also influenced by the presence of local manufacturers producing cost-effective devices, thereby intensifying competition. Government initiatives aimed at improving healthcare infrastructure and increasing investment in research and development are key drivers for the Ophthalmic Viscosurgical Devices market in the Asia-Pacific region.
Market Dynamics and Supply Chain
01
Driver: Rising Prevalence of Ophthalmic Disorders, and Increasing Geriatric Population
The rising occurrence of eye related conditions like cataracts and glaucoma is also driving the need for Ophthalmic Viscosurgical Devices . These devices are also essential, for eye surgeries that prioritize patient safety and enhance surgical results significantly. The growing incidence of these conditions is also projected to boost the OVD markets expansion. The geriatric population is also more prone to eye disorders due to age-related physiological changes. With the global increase in the aging population, the demand for OVDs is also expected to rise, driving the market growth.
The field of ophthalmology is also experiencing progress in technology with the introduction of cohesive and dispersive OVDs that enhance surgical precision and reduce post surgery issues significantly in eye care practices This advancement is also predicted to drive growth in the demand, for OVDs.
02
Restraint: High Cost of Ophthalmic Viscosurgical Devices
The steep prices of Ophthalmic Viscosurgical Devices pose a challenge in the market scene. These unique tools essential for operations like cataract and glaucoma surgeries frequently carry a price. This steep pricing may discourage purchasers especially in underdeveloped areas where healthcare funding is scarce. The elevated costs not only influence the attainability but also the availability of these tools thus influencing the general demand, in the market.
03
Opportunity: Technological Innovations and Exploring Untapped Markets
The field of OVD technology is experiencing a rise in technological progressions with the emergence of cutting edge OVD solutions designed to enhance performance levels and elevate patient results significantly driving market expansion forward. Innovative variations like dispersive OVD options along, with hybrid OVD combinations are reshaping theindustry'sdynamics by offering improved surgical precision control measures that reduce tissue damage and promote quicker post surgery healing processes.
In developing countries like India and China well as Brazil oily eyecare products are gaining popularity because of the growing number of people with eye problems in these areas. They have a population that is increasingly aware of eye health and has access to better healthcare facilities which is likely to boost the demand, for such products.
04
Challenge: Regulatory Hurdles
The OVDs market also faces challenges due to stringent regulatory policies. These devices are subject to rigorous testing and approval processes by regulatory bodies like the FDA, which can be time-consuming and expensive. This results in delayed market entry for new products and can discourage innovation. Furthermore, any changes in regulatory guidelines can lead to additional compliance costs, further restraining market growth.
Supply Chain Landscape
1
Raw Material Suppliers
Dow CorningWacker Chemie AG
2
Component Manufacturers
Carl Zeiss MeditecJohnson & Johnson
3
Device Manufacturers
AlconBausch & Lomb
4
End Users
HospitalsSpecialty ClinicsAmbulatory Surgical Centers
1
Raw Material Suppliers
Dow CorningWacker Chemie AG
2
Component Manufacturers
Carl Zeiss MeditecJohnson & Johnson
3
Device Manufacturers
AlconBausch & Lomb
4
End Users
HospitalsSpecialty ClinicsAmbulatory Surgical Centers
Use Cases of Ophthalmic Viscosurgical Devices in Cataract Surgery & Corneal Transplantation
Cataract Surgery : Ophthalmic Viscosurgical Devices play a pivotal role in cataract surgeries. They are primarily used to create and maintain space, protect delicate ocular tissues, and facilitate intraocular lens implantation. Dispersive OVDs are often preferred in these surgeries due to their high molecular weight and cohesive properties. Leading players such as Alcon and Bausch & Lomb offer advanced OVDs specifically designed for cataract surgeries, contributing significantly to their market position.
Glaucoma Surgery : In glaucoma surgeries, OVDs are used to control and lower intraocular pressure. They aid in the creation of a patent iridotomy and facilitate the placement of shunts or stents. Cohesive OVDs are typically used in these procedures for their ability to maintain a clear surgical field. Top players such as Johnson & Johnson and Carl Zeiss Meditec have a strong market presence in this application, offering innovative OVDs that enhance surgical outcomes.
Corneal Transplantation : OVDs are extensively used in corneal transplantation procedures to protect the endothelium and maintain anterior chamber depth. Balanced OVDs, which combine the properties of both cohesive and dispersive OVDs, are commonly used in these surgeries.
Recent Developments
The global market for Ophthalmic Viscosurgical Devices has been witnessing a significant upswing in recent years. This surge can be attributed to the increasing prevalence of ophthalmic disorders such as cataracts and glaucoma, coupled with the rising geriatric population worldwide.
December 2024 : Johnson & Johnson Vision introduced a next-generation Ophthalmic Viscosurgical Device with advanced fluidic control, significantly improving surgical precision in cataract operations
October 2024 : Alcon Inc. launched a new Ophthalmic Viscosurgical Device with enhanced viscosity, providing better eye protection during surgery and reducing post-operative complications
August 2024 : Bausch & Lomb Incorporated expanded its Ophthalmic Viscosurgical Devices portfolio with a new high-performance device, ensuring superior patient outcomes in vitreoretinal procedures.
Impact of Industry Transitions on the Ophthalmic Viscosurgical Devices Market
As a core segment of the Medical Device industry,
the Ophthalmic Viscosurgical Devices market develops in line with broader industry shifts.
Over recent years, transitions such as Technological Advancements and Regulatory Changes have redefined priorities
across the Medical Device sector,
influencing how the Ophthalmic Viscosurgical Devices market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
Technological Advancements
The OVDs industry has witnessed significant technological advancements in recent years. This transition is primarily driven by the growing demand for minimally invasive surgical procedures and the need for improved patient outcomes. Innovations such as pre-loaded injectors and cohesive and dispersive OVDs have revolutionized the field of ophthalmic surgery. These advancements have not only improved the safety and efficacy of surgeries but have also reduced the recovery time for patients. The impact of these technological advancements is also evident in associated industries such as medical device manufacturing and healthcare services, where the demand for advanced OVDs is on the rise. This industry transition is expected to add $79 million in the industry revenue between 2024 and 2030.
02
Regulatory Changes
The OVDs industry is also undergoing a transition due to changes in regulatory policies. Governments worldwide are implementing stricter regulations to ensure the safety and effectiveness of medical devices. For instance, the introduction of stringent product approval processes and post-market surveillance requirements have compelled manufacturers to maintain high standards of quality.